Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alexis Borisy
Biotech
FogPharma clears $145M series E thanks to Borisy, ex-J&J CEO
We all aspire to have a boss who will just give you money for your next endeavor. Mathai Mammen, M.D., Ph.D., happens to have just that.
Max Bayer
Mar 1, 2024 9:55am
EQRx's low cost drug dream ends in Revolution
Aug 1, 2023 8:49am
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am
Sanofi's John Reed jumps ship for J&J—Chutes & Ladders
Feb 17, 2023 9:30am
New biotech VC takes off with $520M and flight deck of investors
Feb 14, 2023 11:38am
JetBlue, but for biopharma: With $200M, EQRx targets drug prices
Jan 12, 2020 12:13pm